Definiens, Ultivue to Offer Immuno-Oncology Research Solutions
The deal will bring together the companies' respective multiplexed immunofluorescence immunohistochemistry and digital image analysis technologies.
Definiens, Merck KGaA Partner for Biomarker Discovery
Merck will use Definiens' web-based collaboration software platform alongside Definiens' image-analysis technologies for biomarker quantification.
NeoGenomics, Definiens Expand Biomarker Alliance
The companies have expanded their relationship to include the development and automation of assays for clinical trials and clinical testing.
Takeda Adopts Definiens Biomarker Analysis Platform
Takeda will use Definiens' new cloud-based digital pathology platform to conduct analyses for its clinical biomarkers development programs.
Definiens, Indivumed Partner on Cancer Image Analysis, Biomarker R&D
The companies will offer customers access to their technologies and services for cancer image analysis and tissue-based biomarker research and development.